Takeda Pharmaceutical
320 hedge funds and large institutions have $1.25B invested in Takeda Pharmaceutical in 2025 Q3 according to their latest regulatory filings, with 58 funds opening new positions, 132 increasing their positions, 73 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
4% more capital invested
Capital invested by funds: $1.2B → $1.25B (+$44M)
0.23% more ownership
Funds ownership: 2.45% → 2.68% (+0.23%)
Holders
320
Holding in Top 10
–
Calls
$25.3M
Puts
$1.95M
Top Buyers
| 1 | +$44M | |
| 2 | +$27.4M | |
| 3 | +$23.6M | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$20.9M |
| 5 |
AA
ABC Arbitrage
Paris,
France
|
+$8.37M |
Top Sellers
| 1 | -$39.2M | |
| 2 | -$9.79M | |
| 3 | -$7.8M | |
| 4 |
Verition Fund Management
Greenwich,
Connecticut
|
-$6.14M |
| 5 |
BlackRock
New York
|
-$3.56M |
